Fernando
Aranda Vega
Investigador Colaborador
Laura
Senovilla
Publicaciones en las que colabora con Laura Senovilla (8)
2020
-
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Nature Communications, Vol. 11, Núm. 1
-
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (Nature Communications, (2020), 11, 1, (3819), 10.1038/s41467-020-17644-0)
Nature Communications
2018
-
Immune effectors responsible for the elimination of hyperploid cancer cells
OncoImmunology, Vol. 7, Núm. 8
2016
-
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
Cancer Cell, Vol. 30, Núm. 1, pp. 147-160
2015
-
Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer
Oncogene, Vol. 34, Núm. 23, pp. 3053-3062
2014
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508
-
Consensus guidelines for the detection of immunogenic cell death
OncoImmunology, Vol. 3, Núm. 9
-
Impact of myeloid cells on the efficacy of anticancer chemotherapy
Current Opinion in Immunology, Vol. 30, Núm. 1, pp. 24-31